Systemic targeted and immunotherapy for advanced hepatocellular carcinoma.

American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
Robert J Cersosimo

Abstract

The activity of targeted agents and immunotherapy in the management of advanced hepatocellular carcinoma (HCC) is reviewed. The first drug approved by the Food and Drug Administration for advanced HCC, sorafenib, was approved in 2007. Regorafenib, the second drug, was approved 10 years later. Six additional drugs have been approved since. Targeted agents and checkpoint inhibitors are the only agents approved for systemic therapy of advanced HCC. Sorafenib and lenvatinib are approved as first-line agents, with regorafenib, cabozantinib, ramucirumab, nivolumab (used alone or with ipilimumab), and pembrolizumab approved for patients who have received prior sorafenib therapy. Most patients in phase 3 studies had Child-Pugh class A cirrhosis, and data on the use of these agents in patients with more advanced hepatic dysfunction are limited. All of the targeted agents improve survival in patients with advanced disease. Median overall survival durations of up to 12.3 and 13.6 months were reported with use of sorafenib and lenvatinib, respectively, in phase 3 trials. Overall survival durations of 10.6, 10.2, and 9.2 months have been achieved with use of regorafenib, cabozantinib, and ramucirumab as second-line therapy after sorafenib. ...Continue Reading

References

Aug 16, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ghassan K Abou-AlfaLeonard B Saltz
Jul 25, 2008·The New England Journal of Medicine·Josep M LlovetUNKNOWN SHARP Investigators Study Group
Jan 16, 2009·The Oncologist·Matthias PinterMarkus Peck-Radosavljevic
Mar 20, 2010·European Journal of Gastroenterology & Hepatology·Violaine OzenneFrançoise Degos
Mar 30, 2011·Cancer Chemotherapy and Pharmacology·Jeong Eun KimYoon-Koo Kang
Sep 3, 2011·Alimentary Pharmacology & Therapeutics·M PinterM Peck-Radosavljevic
Sep 8, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Massimo IavaroneUNKNOWN SOFIA (SOraFenib Italian Assessment) study group
Sep 24, 2011·European Journal of Gastroenterology & Hepatology·Tianqiang SongWeiwei Ma
Oct 1, 2011·Alimentary Pharmacology & Therapeutics·A HollebecqueP Mathurin
Jan 14, 2012·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Ann-Lii ChengYoon-Koo Kang
Feb 7, 2012·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Dominik BettingerHans Christian Spangenberg
Apr 4, 2012·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Taiga OtsukaUNKNOWN Saga Liver Cancer Study Group
May 2, 2012·American Journal of Clinical Oncology·Bassam EstfanRichard Kim
May 15, 2012·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·Giovan Giuseppe Di CostanzoMassimo De Luca
Aug 10, 2012·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Jon ZugazagoitiaEduardo Díaz-Rubio
Oct 9, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·T PressianiA Santoro
Oct 1, 2013·International Journal of Clinical Pharmacology and Therapeutics·Sun Young Shin, Yu Jeung Lee
Oct 4, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Andrew X ZhuKeith Stuart
Apr 18, 2014·Medical Oncology·Esteban Rodrigo ImedioJoaquin Montalar Salcedo
Oct 3, 2014·World Journal of Hepatology·Masako ShomuraTetsuya Mine
Jul 15, 2015·Molecular and Clinical Oncology·Leonardo Gomes DA FonsecaJorge Sabbaga
Aug 19, 2015·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Amit G Singal, Hashem B El-Serag
Oct 17, 2015·Cancer Medicine·Masahito NakanoUNKNOWN Kurume Liver Cancer Study Group of Japan
Feb 25, 2017·Annals of Hepatology·Amy ShriverPatrick Northup
Jul 13, 2017·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Tom M GantenGuido Gerken
Jun 28, 2018·Investigational New Drugs·Cassia Regina Guedes LealSérgio Setubal
Jul 5, 2018·The New England Journal of Medicine·Ghassan K Abou-AlfaRobin K Kelley

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.